CXCR2 and hepatocellular carcinoma: Receptor-interacting protein kinase 3 (RIP3) knockdown promotes tumor progression and immune escape through driving MDSC recruitment by CXCR2 and decreasing interferon (IFN)-γ+ CD8+ T cells in hepatocellular carcinoma (HCC) [107].